ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,417Medicare Part D Prescriptions Filled, Including Refills

Rank: 293 out of 1111

$462K Total Retail Price of All Prescriptions

Rank: 253 out of 1111

445 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 445 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 5,755 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 424 246 S3 1 1
OMEPRAZOLE 264 210 2 4
LISINOPRIL 240 214 3 2
SIMVASTATIN 235 231 4 5
FUROSEMIDE 210 189 5 6
POTASSIUM CHLORIDE 203 160 6 9
MELOXICAM 194 148 7 18
METFORMIN HCL 175 141 8 8
DONEPEZIL HCL 123 123 9 25
HYDROCHLOROTHIAZIDE 117 104 10 11
LEVOTHYROXINE SODIUM 103 92 11 3
ZOLPIDEM TARTRATE 98 57 12 16
AMLODIPINE BESYLATE 97 94 13 7
METOPROLOL SUCCINATE 93 72 14 20
AZITHROMYCIN 93 67 14 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 58 16 23
TRAMADOL HCL 83 50 17 13
DIGOXIN 81 81 18 47
SERTRALINE HCL 81 70 18 24
NEXIUM 73 66 20 26
NAMENDA 68 67 21 31
TAMSULOSIN HCL 65 56 22 28
GABAPENTIN 64 57 23 10
ATENOLOL 63 43 24 22
ALLOPURINOL 60 60 25 36
CLOPIDOGREL 57 54 26 30
CARVEDILOL 57 45 26 21
CYMBALTA 55 26 28 40
METOPROLOL TARTRATE 54 53 29 12
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 47 29 71
LOSARTAN-HYDROCHLOROTHIAZIDE 53 48 31 72
WARFARIN SODIUM 51 47 32 19
GLYBURIDE 50 36 R 33 59
CELEBREX 50 50 33 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.